Philips SymphonySuite to Integrate Biotronik Cardiovascular Products for OBL and ASC Procedures

June 21, 2023—Royal Philips announced a strategic alliance with Biotronik to expand the range of cardiovascular devices available for Philips SymphonySuite customers.

The Philips SymphonySuite is the company’s solution for opening and expanding cardiovascular office-based labs (OBLs) and ambulatory surgery centers (ASCs). The company noted that SymphonySuite includes a full range of high-performing, highly specialized equipment and devices, personalized services, financing options, site planning, ongoing operational support, and device programs.

Philips stated that with more procedures moving to out-of-hospital care settings such as OBLs and ASCs, the combination of SymphonySuite and the full range of Biotronik’s cardiac rhythm management (CRM), cardiovascular intervention, and peripheral vascular intervention product portfolios provides more options to individualize patient care and create treatment strategies for low-risk cardiac procedures performed in these settings.

According to Philips, health care providers continue to support the shift of care settings because of patient demand, improvements in medical technology, and operational benefits. Out-of-hospital care settings increase access to care and allow for a more personalized patient experience with a lower risk of hospital-acquired infections for patients. In general, procedures performed in out-of-hospital settings have lower overhead and capital costs. These savings help drive lower costs for patients, advised the company.

In its press release, Philips cited findings that approximately 66% of catheterization lab procedures—including CRM implantations, peripheral artery disease diagnostic catheterizations, and percutaneous coronary interventions—can currently be comfortably performed in an ASC setting. It is anticipated that by 2030, 82% of all outpatient cardiovascular procedures will be appropriate for migration from the hospital to ASCs, which have demonstrated lower rates of hospital-acquired infections.

Chris DeCarolis, Head of Procedural Solutions for Image Guided Therapy at Philips, commented in the company’s press release, “Philips is committed to expanding access to care through its innovative solutions, and Biotronik’s alliance adds additional devices, including a CRM portfolio, to SymphonySuite. We will continue to evolve to stay ahead of the needs of physicians and patients and provide cardiovascular equipment, devices, and services in out-of-hospital settings while reducing cost pressures via innovative business models.”

Atul Suri, Vice President of Commercial Excellence at Biotronik, added, “Through Biotronik’s innovative cardiovascular technologies, we’re committed to partnering with outpatient sites of service. Aligning with Philips will allow us to bring greater value to our outpatient customers, particularly those with capital equipment needs for ASC and OBL facilities.”